The Biochemical Bone Marker Market - Dawn or Dusk?
This article was originally published in Clinica
Biochemical bone marker tests, especially those for bone resorption, are on the brink of being established as a routine tool in the management of osteoporosis. Until two years ago, the new market of resorption tests was one of the fastest growing sectors in immunodiagnostics. Nonetheless, the share prices of the two main players - Metra Biosystems and Ostex International - have reached an all-time low of below $1.00.